Resmed (ASX:RMD) Chief Executive Michael Farrell sold 8,009 of his shares in the company on the New York Stock Exchange, with an aggregate market value of roughly $1.9 million, according to a Monday filing with the Australian bourse.
Following the transaction, Farrell now owns nearly 146.9 million shares and other units outstanding in the company, the filing said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.